LINC01333

Across TCGA pan-cancer cohorts, LINC01333 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated LINC01333 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC01333 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01333 expression acts as an unfavorable survival marker, although some lineages such as LGG and LUSC show a favorable association.

ACC, ESCA, and BLCA are the cancer types where LINC01333 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.114	0.892	<.001	72	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
BLCA	OS	Tertile	IV	0.035	0.606	<.001	27	view →
PCPG	OS	Tertile	All	0.792	0.974	.015	27	view →
LIHC	OS	Tertile	All	0.169	0.669	.032	18	view →
LGG	OS	Tertile	All	0.664	0.404	.031	9	view →
KIRC	OS	Tertile	All	0.447	0.646	.037	6	view →
LUSC	DFS	Tertile	All	1.000	0.739	.033	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

LINC01333–ACC (OS)

Open the ACC breakdown →